SZi001+Abstract+text+only.pdf (16.92 kB)
Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]
journal contribution
posted on 2017-08-16, 09:01 authored by S. Ziya, Nick Medcalf, Alicia J. El Haj, K.T. WrightFacilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]
History
School
- Mechanical, Electrical and Manufacturing Engineering
Published in
CYTOTHERAPYVolume
19Issue
5Pages
S89 - S89Citation
ZIYA, S. ... et al, 2017. Facilitating the operational readiness of the NHS for the in-house manufacture and delivery of autologous cell therapy [210]. Cytotherapy, 19 (5), Supplement, p.S89.Publisher
© ElsevierVersion
- AM (Accepted Manuscript)
Publisher statement
This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/Publication date
2017Notes
This paper was published in the journal Cytotherapy and the definitive published version is available at https://doi.org/10.1016/j.jcyt.2017.02.219. This is the abstract for a poster presented at the ISCT 2017 Annual Meeting.ISSN
1465-3249eISSN
1477-2566Publisher version
Language
- en